Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2003
12/04/2003US20030224004 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030224003 Administering to a mammal a preparation containing a portion of the amino acid sequence of mature adenylate cyclase of a second Bordetella species for immunizing the mammal against infection by a first Bordetella species
12/04/2003US20030223995 Treatment of pemphigus vulgaris
12/04/2003US20030223993 Novel steroid-activated nuclear receptors and uses therefor
12/04/2003US20030223992 G-protein coupled receptor ligands and methods
12/04/2003US20030223990 A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers. 193P1E1 provides
12/04/2003US20030223985 Globulin protein to lower cholesterol in humans
12/04/2003US20030223984 Isolated from the genus Carica are provided. In particular the proteases are cysteine proteases isolated from Carica candamarcensis. In addition, the recombinant forms of the protease, including fragments and mutants with substantial
12/04/2003US20030223983 Formulation comprising bioactive agents and method of using same
12/04/2003US20030223982 Enzymes in topical cosmetic or pharmaceutical compositions for the prevention of the ageing of human skin. In particular, the method prevents ageing effects caused by light. The method prevents the degradation of collagen within connective tissue
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030223980 Uses of thioredoxin
12/04/2003US20030223977 Novel small proteins which bind cathepsin G have been identified. These are useful as inhibitors of excessive cathepsin G activity in patients.
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223975 Based on the discovery that a Y-box protein binding site is present as a transcription enhancer sequence in the promoter region situated upstream (i.e., 5' to) of the human PTP1B gene. This site, situated at nucleotides -155 through -132 of
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223971 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
12/04/2003US20030223970 Methods and compounds for prevention of graft rejection
12/04/2003US20030223969 Method of modulating inflammatory response
12/04/2003US20030223966 Treatment for pompe disease
12/04/2003US20030223965 Bone generation by gene therapy
12/04/2003US20030223964 Efficient expression of HIV polypeptides in a variety of cell types, including, but not limited to, mammalian, insect, and plant cells. Synthetic expression cassettes encoding the HIV Gag-containing polypeptides are described, as are uses of the
12/04/2003US20030223962 Delivery of gene products to the lung parenchyma via gene transfer to the pleura
12/04/2003US20030223961 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
12/04/2003US20030223958 Use of interleukin-19 to treat ovarian cancer
12/04/2003US20030223953 Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof
12/04/2003US20030223949 Use of a polypeptide for treatment of pruritus in animals
12/04/2003US20030223936 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/04/2003US20030222461 Anti-panic opening system for doors
12/04/2003US20030222364 Method and apparatus for producing dry particles
12/04/2003US20030221931 Sliding device
12/04/2003CA2525976A1 Modulation of ptp1b signal transduction by rna interference
12/04/2003CA2513388A1 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003CA2496618A1 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
12/04/2003CA2494134A1 Treatment for diabetes
12/04/2003CA2493902A1 Decoy composition for treating and preventing inflammatory disease
12/04/2003CA2490542A1 Fas peptide mimetics and uses thereof
12/04/2003CA2487655A1 Methods and compositions for inhibiting hiv replication
12/04/2003CA2487557A1 Modulators and inhibitors of fibroblast growth factor receptor 5 polypeptides and gene expression thereof
12/04/2003CA2487452A1 A method for generating antigen-presenting cells
12/04/2003CA2487441A1 Novel uses of parapoxvirus preparations
12/04/2003CA2487419A1 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation
12/04/2003CA2487351A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003CA2487303A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003CA2487273A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003CA2487269A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003CA2487246A1 Novel uses of cephaibols
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2487112A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003CA2486967A1 Cardiolipin compositions their methods of preparation and use
12/04/2003CA2486918A1 Novel chimeric cd154
12/04/2003CA2486909A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003CA2486622A1 Aerosol drug inhibition of lung metastases
12/04/2003CA2486621A1 Induction and maintenance of tolerance to composite tissue allografts
12/04/2003CA2486620A1 Chimeric allograft tolerance induction, monitoring and maintenance
12/04/2003CA2486615A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
12/04/2003CA2486113A1 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003CA2485984A1 Pharmaceutical combination of pde5 inhibitors with ace inhibitors
12/04/2003CA2485972A1 Method for the use of pyranoindole derivatives to treat infection with hepatitis c virus
12/04/2003CA2485648A1 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003CA2485485A1 Antagonistic peptides of prostaglandin e2 receptor subtype ep4
12/04/2003CA2484656A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2480548A1 Compositions and methods of use for a bombesin peptide
12/04/2003CA2480011A1 Dentritic cell nodes
12/03/2003EP1367396A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 10 (CCR10)
12/03/2003EP1367393A1 Methods for using the CD 163 pathway for modulating an immune response
12/03/2003EP1367124A1 5' ests for secreted proteins expressed in muscle and other mesodermal tissues
12/03/2003EP1367065A1 Acid soluble proteins from micellar casein
12/03/2003EP1367064A1 Inhibitors of proteins from the Rho-GEF family
12/03/2003EP1367063A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367062A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367061A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1366773A1 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
12/03/2003EP1366772A1 Gm-csf and/or defensin protein expression regulators in epithelial cells comprising ets transcription factor or gene encoding the same
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003EP1366768A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/03/2003EP1366765A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366363A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366174A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus
12/03/2003EP1366167A2 Biological organism for preparing pharmaceutical compositions for treating mammals
12/03/2003EP1366166A2 Molecules for diagnostics and therapeutics
12/03/2003EP1366165A2 G-protein coupled receptors
12/03/2003EP1366164A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals
12/03/2003EP1366163A2 Methods and compositions for modifying a receptor tyrosine kinase/protein tyrosine kinase signal to an apoptotic signal in a cell
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366161A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof
12/03/2003EP1366157A2 Compositions and methods for the therapy and diagnosis of lung cancer
12/03/2003EP1366156A2 Osteolevin gene polymorphisms
12/03/2003EP1366155A1 Methods and agents for modifying human angiogenesis
12/03/2003EP1366152A2 G-protein coupled receptors
12/03/2003EP1366151A2 Prna chimera
12/03/2003EP1366150A2 Use of protein histidine phosphatase
12/03/2003EP1366149A2 Modified target enzymes having catalytic triads and uses thereof
12/03/2003EP1366147A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27
1 ... 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 ... 3163